About
Leadership
Careers
Contact Us
Technology
Autologous Fibroblast Technology
Manufacturing
Publications
Pipeline
D-Fi Gene Therapy for Dystrophic Epidermolysis Bullosa (DEB)
Patients & Families
Epidermolysis Bullosa (EB)
Contact Us
Toggle navigation
Leadership
About
Leadership
Matthew Gantz, M.B.A.
Chairman and Chief Executive Officer
Read Bio
David Chu, M.D., Ph.D., F.A.A.D.
Chief Medical Officer
Read Bio
Rhea Williams, M.P.H.
Vice President, Regulatory Affairs
Read Bio
Matthew Crabtree
Vice President, Finance
Read Bio
